Literature DB >> 11799480

Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.

Giorgio Ballardini1, Emilio De Raffele, Paolo Groff, Paulette Bioulac-Sage, Alberto Grassi, Sabrina Ghetti, Micaela Susca, Mario Strazzabosco, Roberto Bellusci, Rosa Maria Iemmolo, Gianluca Grazi, Daniela Zauli, Antonino Cavallari, Francesco Bianco Bianchi.   

Abstract

Pathogenic mechanisms and dynamics of hepatitis C virus (HCV) reinfection in orthotopic liver transplantation (OLT) are poorly defined. This study focuses on these aspects by studying 55 frozen biopsy specimens from transplant recipients with various histological diagnoses obtained from 4 days to 4 years post-OLT and 10 patients with HCV-related chronic hepatitis. The percentage of HCV-infected hepatocytes, number and distribution of CD8 and natural killer cells, and rates of hepatocellular apoptosis and proliferation were quantified by immunohistochemistry. HCV antigens were detected in 37% of biopsy specimens obtained within 20 days and 90% of biopsy specimens obtained from 21 days to 6 months after OLT. The number of HCV-infected hepatocytes was never less than 40% in acute hepatitis specimens and never greater than 30% in the other cases. Hepatocellular apoptosis was high in biopsy specimens of acute hepatitis and moderate in those from transplant recipients with normal histological characteristics, but still greater than in specimens of chronic active hepatitis. Proliferation correlated significantly with apoptosis. Lymphocyte infiltration was high and similar among cases of acute hepatitis, chronic hepatitis, and rejection. These data: (1) show that the detection of liver HCV antigens is sensitive enough to be used in clinical practice as a diagnostic tool to detect infection of the transplanted liver and might be useful, combined with conventional histological evaluation to detect hepatitic damage, for therapeutic decision making; (2) suggest direct cytotoxicity of HCV, as well as immunologic mechanisms possibly prevalent in chronic hepatitis and rejection, at least in the phase of acute massive liver infection; and (3) show that hepatocellular apoptosis and regeneration might be active enough to lead to replacement of the entire transplanted liver in 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799480     DOI: 10.1053/jlts.2002.30141

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

Review 1.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival.

Authors:  Pratima Sharma; Amy Hosmer; Henry Appelman; Barbara McKenna; Mohammad S Jafri; Patricia Sullivan; Robert J Fontana; Anna S Lok
Journal:  Hepatol Int       Date:  2013-10       Impact factor: 6.047

Review 3.  Impact of new treatment options for hepatitis C virus infection in liver transplantation.

Authors:  Elda Righi; Angela Londero; Alessia Carnelutti; Umberto Baccarani; Matteo Bassetti
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 4.  Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.

Authors:  Eu Jin Lim; Ruth Chin; Peter W Angus; Joseph Torresi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

5.  Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors.

Authors:  Valeria R Mas; Kellie J Archer; Lacey Suh; Mariano Scian; Marc P Posner; Daniel G Maluf
Journal:  Transplantation       Date:  2010-12-15       Impact factor: 4.939

6.  Strategies to reduce hepatitis C virus recurrence after liver transplantation.

Authors:  Ruben Ciria; María Pleguezuelo; Shirin Elizabeth Khorsandi; Diego Davila; Abid Suddle; Hector Vilca-Melendez; Sebastian Rufian; Manuel de la Mata; Javier Briceño; Pedro López Cillero; Nigel Heaton
Journal:  World J Hepatol       Date:  2013-05-27

7.  Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

Authors:  Sarah L Fishman; Jacinta M Murray; Francis J Eng; José L Walewski; Susan Morgello; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 8.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 9.  Human liver transplantation as a model to study hepatitis C virus pathogenesis.

Authors:  Michael G Hughes; Hugo R Rosen
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

10.  Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection.

Authors:  Zina Meriden; Kimberly A Forde; Theresa L Pasha; Jia-Ji Hui; K Rajender Reddy; Emma E Furth; Rebecca G Wells
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-12       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.